Cannabidiol (CBD): What we know and what we don't

The Harvard Health article examines cannabidiol (CBD), a non-psychoactive compound derived from cannabis, and its potential health benefits. CBD has shown efficacy in treating certain childhood epilepsy syndromes, leading to FDA approval of Epidiolex. Preliminary research suggests CBD may alleviate anxiety, insomnia, and chronic pain by interacting with the endocannabinoid system, which plays a role in regulating mood, sleep, and pain perception. However, comprehensive human studies are lacking, and the safety profile of CBD, including potential liver damage and interactions with other medications, is not fully understood. Given the current evidence, it's advisable to approach CBD use cautiously. For brain health, focusing on well-established lifestyle practices—such as regular physical activity, a balanced diet, sufficient sleep, and stress-management—is recommended over unproven supplements like CBD.